Form 8-K CAL-MAINE FOODS INC For: Jul 22
0000016160
False
☐
☐
☐
☐
0000016160
2026-07-22
2026-07-22
UNITED STATES SECURITIES AND EXCHANGE COMMISSIONS WASHINGTON, DC 20549 FORM 8-KCURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act. Date of Report (Date of Earliest Event Reported): July 22, 2026Cal-Maine Foods, Inc.(Exact name of registrant as specified in its charter) Delaware001-3869564-0500378(State or other... (continue reading...)
Form 6-K Banco Santander, S.A. For: Jun 30
http://archive.fast-edgar.com/20260722/AA229222Z22U62Z2222D22EZQMICJZN2A282
Filed on: July 22, 2026
Form 6-K/A SuperX AI Technology For: Jul 22
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K/A
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULES 13a-16 AND 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of July 2026
Commission File Number 001-42013
SuperX AI Technology Limited
(Translation of registrant’s name into English)
30 Pasir Panjang Road
#06-31, Mapletree Business City
Singapore 117440
(Address of principal... (continue reading...)
Form 4 Sea Ltd For: Jul 20 Filed by: Ye Gang
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 8-K Otis Worldwide Corp For: Jul 22
0001781335FALSE00017813352026-07-222026-07-220001781335us-gaap:CommonStockMember2026-07-222026-07-220001781335otis:A0318NotesDue2026Member2026-07-222026-07-220001781335otis:Notes2.875Due2027Member2026-07-222026-07-220001781335otis:A0934NotesDue2031Member2026-07-222026-07-22UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549____________________________________ FORM 8-K____________________________________ CURRENT REPORTPursuant to Section 13 OR 15(d) of... (continue reading...)
More SEC Filings
View Older Stories-
Form 4 Sea Ltd For: Jul 20 Filed by: Wang Yanjun
-
Form 13F-HR Sumitomo Mitsui DS Asset For: Jun 30
-
Form 6-K EQUINOR ASA For: Jul 22
-
Form 6-K EQUINOR ASA For: Jul 22
-
Form FWP SCE Recovery Funding Filed by: SCE Recovery Funding LLC
-
Form 6-K SK hynix Inc. For: Jul 22
-
Form FWP VanEck Merk Gold ETF Filed by: VanEck Merk Gold ETF
-
Form 424B2 JPMORGAN CHASE & CO
-
Form S-6/A Advisors Disciplined
-
Form EFFECT Our Bond, Inc.
-
Form 425 ENDRA Life Sciences Inc. Filed by: ASP Isotopes Inc.
-
Form EFFECT Lyell Immunopharma, Inc.
-
Form SCHEDULE 13G/A Flywire Corp Filed by: Temasek Holdings (Private) Ltd
-
Form 6-K Banco Santander, S.A. For: Jun 30
-
Form 8-K NEXT-ChemX Corporation. For: Jul 17
-
Form FWP SOUTHERN CALIFORNIA EDIS Filed by: SOUTHERN CALIFORNIA EDISON Co
-
Form 6-K ATA Creativity Global For: Jul 22
-
Form 6-K monday.com Ltd. For: Jul 22
-
Form 6-K SK hynix Inc. For: Jul 22
-
Form 6-K NOMURA HOLDINGS INC For: Jul 22
-
Form EFFECT Outlook Therapeutics,
-
Form EFFECT FREQUENCY ELECTRONICS
-
Form EFFECT NN INC
-
Form 6-K WOODSIDE ENERGY GROUP For: Jul 22
-
Form EFFECT Weatherford Internationa
-
Form EFFECT Bravalo Corp
-
Form EFFECT NewtekOne, Inc.
-
Form EFFECT PDS Biotechnology Corp
-
Form EFFECT HAWTHORN BANCSHARES,
-
Form D/A Tareyton Fund I, L.P.
-
Form 425 Passage BIO, Inc. Filed by: Passage BIO, Inc.
-
Form 424B2 CITIGROUP INC
-
Form FWP ROYAL BANK OF CANADA Filed by: ROYAL BANK OF CANADA
-
Form D Benson Co-investment
-
Form D/A Fund I, a series of Outl
-
Form 13F-HR Lakehouse Capital Pty For: Jun 30
-
Form D Insolent-GO-0613 Fund
-
Form D Mainspring Funding II
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form FWP ROYAL BANK OF CANADA Filed by: ROYAL BANK OF CANADA
-
Form 13F-HR Q Fund Management (Hong For: Jun 30
-
Form N-PX DRIVE WEALTH MANAGEMENT, For: Jun 30
-
Form 424B2 BARCLAYS BANK PLC
-
Form D DHVP SPV V, a series of
-
Form FWP ROYAL BANK OF CANADA Filed by: ROYAL BANK OF CANADA
-
Form C Intelligent Clinical
-
Form 13F-NT Hang Seng Investment For: Jun 30
-
Form 6-K Clinuvel Pharmaceuticals For: Jul 21
-
Form 6-K RedCloud Holdings plc For: Jul 21
-
Form D NE-0312 Fund I, a series
